Literature DB >> 9804718

Facial vasculitic rash associated with intravenous immunoglobulin.

M Howse1, L Bindoff, A Carmichael.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9804718      PMCID： PMC28711          DOI： 10.1136/bmj.317.7168.1291

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Alopecia after immunoglobulin infusion.

Authors:  D Chan-Lam; E J Fitzsimons; W S Douglas
Journal:  Lancet       Date:  1987-06-20       Impact factor: 79.321

2.  Eczema after intravenous infusion of immunoglobulin.

Authors:  C Barucha; J C McMillan
Journal:  Br Med J (Clin Res Ed)       Date:  1987-10-31

3.  Vasculitis in systemic lupus erythematosus following intravenous immunoglobulin therapy.

Authors:  P J Hashkes; D J Lovell
Journal:  Clin Exp Rheumatol       Date:  1996 Nov-Dec       Impact factor: 4.473

Review 4.  Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature.

Authors:  C Schiavotto; M Ruggeri; F Rodeghiero
Journal:  Haematologica       Date:  1993 Nov-Dec       Impact factor: 9.941

5.  Complications of intravenous immune globulin treatment in neurologic disease.

Authors:  T H Brannagan; K J Nagle; D J Lange; L P Rowland
Journal:  Neurology       Date:  1996-09       Impact factor: 9.910
  5 in total
  1 in total

Review 1.  Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders.

Authors:  Andreas Steinbrecher; Peter Berlit
Journal:  J Neurol       Date:  2006-09       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.